0001438133-21-000228.txt : 20211209
0001438133-21-000228.hdr.sgml : 20211209
20211209162410
ACCESSION NUMBER: 0001438133-21-000228
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211207
FILED AS OF DATE: 20211209
DATE AS OF CHANGE: 20211209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gasser Elizabeth Anne
CENTRAL INDEX KEY: 0001866283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 211482267
MAIL ADDRESS:
STREET 1: C/O TANDEM DIABETES CARE, INC.
STREET 2: 11075 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_163908503560052.xml
FORM 4
X0306
4
2021-12-07
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001866283
Gasser Elizabeth Anne
C/O TANDEM DIABETES CARE, INC.
11075 ROSELLE STREET
SAN DIEGO
CA
92121
0
1
0
0
EVP, Chief Strategy Officer
Common Stock
2021-12-07
4
M
0
797
89.54
A
1228
D
Common Stock
2021-12-07
4
M
0
286
82.34
A
1514
D
Common Stock
2021-12-07
4
S
0
1083
140
D
431
D
Stock Option
89.54
2021-12-07
4
M
0
797
89.54
A
Common Stock
797.0
21514
D
Stock Option
82.34
2021-12-07
4
M
0
286
82.34
A
Common Stock
286.0
8601
D
Represents shares of common stock received upon exercise of a stock option award.
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.
The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
The expiration date for these options is 10 years from the date of grant.
The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.
s/ David B. Berger, Attorney-in-Fact for Elizabeth A. Gasser
2021-12-09